The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies.

MLA

Berg, Anastasia L., et al. “The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies.” Cancers, vol. 14, no. 4, Feb. 2022. EBSCOhost, https://doi.org/10.3390/cancers14040949.

APA

Berg, A. L., Rowson-Hodel, A., Hu, M., Keeling, M., Wu, H., VanderVorst, K., Chen, J. J., Hatakeyama, J., Jilek, J., Dreyer, C. A., Wheeler, M. R., Yu, A.-M., Li, Y., & Carraway, K. L., 3rd. (2022). The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies. Cancers, 14(4). https://doi.org/10.3390/cancers14040949

Chicago

Berg, Anastasia L, Ashley Rowson-Hodel, Michelle Hu, Michael Keeling, Hao Wu, Kacey VanderVorst, Jenny J Chen, et al. 2022. “The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies.” Cancers 14 (4). doi:10.3390/cancers14040949.